Roche Gets European Marketing Clearance for New HIV-1 Molecular Assay

Dec 15, 2008

NEW YORK (GenomeWeb News) – Roche has received the CE-IVD Mark for its new dual-target HIV-1 test allowing it to be used for clinical use throughout the European Union, the firm said today.

The firm’s Cobas AmpliPrep/Cobas TaqMan HIV-1 Test, v2.0 simultaneously amplifies and detects two separate regions of the HIV-1genome, which Roche said enables reliable results even when mutations are present. The test also uses real-time PCR to quantify the amount of HIV-1RNA in a patient’s blood.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Better Recovery

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

Science 'Critical Thinking' Bill in South Dakota

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

This Week in Science

In Science this week: the synthetic genetic system hachimoji, and more.

No More

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

Main menu